Ankylosing spondylitis is a chronic inflammatory condition that primarily affects the spine and the sacroiliac joints, but its effects can extend well beyond the musculoskeletal system. Because it is an autoimmune disorder, the immune system mistakenly attacks healthy tissues, leading to widespread inflammation. Among the less commonly recognized complications are inner ear problems that can cause hearing loss, dizziness, and balance difficulties. This article explores the relationship between ankylosing spondylitis and inner ear disease, focusing on hearing, dizziness, and the autoimmune mechanisms at work.
Understanding Ankylosing Spondylitis
Ankylosing spondylitis is a form of inflammatory arthritis that often begins in early adulthood. The hallmark symptom is inflammatory back pain, which is worse at night and improves with exercise. Over time, the inflammation can cause new bone formation on the spine, leading to stiffness and, in severe cases, fusion of the vertebrae. However, ankylosing spondylitis is a systemic disease, meaning it can affect multiple organ systems. Inflammation of the eye, the bowel, and the heart has long been recognized. The inner ear is another target of this systemic autoimmune process.
Hearing Loss in Ankylosing Spondylitis
Hearing impairment is a significant and often overlooked comorbidity in people with ankylosing spondylitis. Numerous clinical studies have shown that sensorineural hearing loss occurs more frequently in patients with ankylosing spondylitis than in the general population. This type of hearing loss arises from damage to the inner ear (cochlea) or the auditory nerve, rather than to the outer or middle ear. The hearing loss is often bilateral and tends to affect higher frequencies, which can make it difficult to understand speech in noisy environments. In some cases, the hearing loss is subclinical, meaning it is only detectable through audiometric testing. Less commonly, patients may experience sudden hearing loss or fluctuating hearing thresholds, which can be distressing and require prompt evaluation.
The precise cause of hearing loss in ankylosing spondylitis is not fully understood. The autoimmune inflammation that characterizes the disease may directly damage the delicate hair cells of the cochlea. Inflammatory cytokines, such as tumor necrosis factor-alpha, are elevated in ankylosing spondylitis and may contribute to cellular injury in the inner ear. Additionally, immune complexes or autoantibodies could target inner ear structures, leading to progressive damage over time.
Dizziness and Vestibular Dysfunction
Dizziness and vertigo are also more common among individuals with ankylosing spondylitis. The vestibular system, which resides in the inner ear and includes the semicircular canals and otolith organs, is responsible for maintaining balance and spatial orientation. When this system is affected by inflammation, patients may experience a sensation of spinning (vertigo), unsteadiness, or a feeling of floating. These symptoms can be constant or episodic and may be triggered by head movements or changes in position.
Vestibular dysfunction in ankylosing spondylitis often accompanies hearing loss, although it can occur independently. The blood supply to the inner ear may be compromised by systemic inflammation, leading to ischemic injury to both the cochlear and vestibular end organs. Alternatively, the autoimmune response may directly target vestibular neurons or hair cells. In some patients, dizziness may be exacerbated by neck stiffness and altered posture, which interfere with the integration of visual, proprioceptive, and vestibular input. However, in many cases, the cause can be traced to the inner ear itself.
The Autoimmune Connection
Ankylosing spondylitis is classified as an autoimmune disease because the immune system attacks self-antigens, particularly in the joints and entheses. The same dysregulated immune response may extend to the inner ear. The inner ear is not an immunologically privileged site; immune cells can access it during inflammation, and inflammatory mediators can cause significant damage. Research has suggested that autoantibodies against inner ear proteins, such as cochlin or type II collagen, may be present in some patients with autoimmune inner ear disease. Although this condition is more commonly associated with other autoimmune diseases, such as systemic lupus erythematosus or rheumatoid arthritis, it can also occur in the setting of ankylosing spondylitis.
Tumor necrosis factor-alpha is a key driver of inflammation in ankylosing spondylitis. Elevated levels of this cytokine have been found in the blood of affected individuals, and it is known to promote inflammation in many tissues, including the inner ear. This has led to interest in whether biologic agents that block tumor necrosis factor-alpha, such as infliximab or adalimumab, could improve or stabilize hearing and balance in patients with ankylosing spondylitis. Some case reports and small studies have shown promising results, but larger controlled trials are still needed before routine use can be recommended.
Clinical Recommendations
Given the increased prevalence of hearing loss and dizziness in ankylosing spondylitis, healthcare providers should proactively ask affected individuals about these symptoms. Simple questions about difficulty hearing conversations, tinnitus (ringing in the ears), or episodes of vertigo can help identify those who need further assessment. An audiogram is a non-invasive test that can detect sensorineural hearing loss even in its early stages. Vestibular testing, such as videonystagmography or posturography, may be helpful for patients who experience dizziness or imbalance that is not explained by other causes.
For patients diagnosed with inner ear involvement, management should focus on both the underlying inflammatory disease and the ear-specific symptoms. Controlling systemic inflammation with appropriate treatment, including biologics, may reduce further damage to the inner ear. Hearing aids are effective for hearing loss, and vestibular rehabilitation therapy can help the brain adapt to balance deficits. Patients with sudden hearing loss or severe vertigo should be evaluated urgently, as early intervention may improve outcomes.
Conclusion
Ankylosing spondylitis is more than a disease of the spine. Its autoimmune nature can affect many parts of the body, including the inner ear, leading to hearing loss and dizziness. These complications are often under-recognized, but they can have a profound impact on quality of life. Increased awareness among patients and clinicians is essential for early detection and management. If you have ankylosing spondylitis, discuss any hearing or balance concerns with your healthcare professional, as these problems may be treatable. Further research into the autoimmune pathways that link ankylosing spondylitis and inner ear disease will help develop more targeted therapies in the future.